Defining refractory myocardial infarction-associated cardiogenic shock: an ongoing elusive challenge.
Bruno
B
Mégarbane
Sébastian
S
Voicu
Nicolas
N
Deye
Frédéric J
FJ
Baud
D016887:Cardiopulmonary Resuscitation / Q000379:methods; D003131:Combined Modality Therapy; D004280:Dobutamine / Q000008:administration & dosage* / Q000009:adverse effects; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D012770:Shock, Cardiogenic / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D016019:Survival Analysis
D004280:Dobutamine